[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Intravenous (IV) Hydration Therapy Market By Service (Immune boosters, Energy boosters, Skin care, Migraine, Others), By Component (Medicated, Non-medicated) By End user (Hospital & clinics, Wellness centers & spas, Home healthcare, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

July 2024 | 220 pages | ID: IEA21264B730EN
Allied Market Research

US$ 2,655.00

E-mail Delivery (PDF), Online Subscription, Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Intravenous (IV) Hydration Therapy Market

The intravenous (IV) hydration therapy market was valued at $2.3 billion in 2023 and is projected t%li%reach $4.9 billion by 2033, growing at a CAGR of 7.8% from 2024 t%li%2033.

Intravenous (IV) hydration therapy is the medical procedure in which medications, fluids, vitamins, and electrolytes are infused directly int%li%the bloodstream through a vein. The therapy is a highly effective procedure as it ensures efficient and quick replenishment of essential fluids and nutrients lost due t%li%dehydration. Dehydration is the excessive loss of fluids from the body caused by some illness, excessive alcohol consumption, or intense physical activity. The treatment is applicable in diverse medical settings for the management of chronic conditions, preoperative & postoperative care, and t%li%cure patients with severe infections or gastrointestinal problems.

One of the key drivers of the intravenous (IV) hydration therapy market is increase in uptight lifestyle among individuals with high stress levels. A stressed lifestyle is one of the most common reasons for rising dehydration among individuals. In addition, the geriatric population is growing exponentially across the globe, wh%li%are highly susceptible t%li%ailments and hospitalization. This boosts the demand for IV hydration therapy, thus augmenting the market growth. In recent times, the administration of IV therapy as a part of self-care routine or rejuvenation is trending, particularly among celebrities. Moreover, specialized centers called “hydration bars” are being established for people t%li%receive therapy as a form of relaxation.

However, the availability of other alternatives for hydration therapy, such as the oral rehydration solutions restrain the development of the market. Furthermore, the shortage of dedicated medical facilities and well-trained staff, particularly in rural areas, presents challenges for the expansion of the market. On the contrary, advancements in technology and modifications in the conventional formulations administered during treatment are presenting lucrative opportunities for market growth. For instance, personalized solutions are being developed according t%li%the requirements of every individual, hence aiding them t%li%achieve their health goal.

Segment Review

The intravenous (IV) hydration therapy market is segmented int%li%service, component, end user, and region. On the basis of service, the market is divided int%li%immune boosters, energy boosters, skin care, migraine, and others. By component, it is bifurcated int%li%medicated and non-medicated. As per end user, it is categorized int%li%hospital & clinics, wellness centers & spas, home healthcare, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of service, the immune boosters segment dominates the market.

By component, the medicated segmented experiences significant demand in the market.

As per end user, the hospital & clinics segment acquires a high share of the market.

Region wise, North America leads the market.

Competition Analysis

The major players operating in the global intravenous (IV) hydration therapy market include Davita, Nikkis%li%Co. Ltd., Core IV Therapy, LLC, Cryojuvenate UK Ltd., B. Braun Medical Inc., Otsuka Pharmaceutical Co., Ltd., NexGen Health, JW Life Science Corporation, Amanta Healthcare Limited., and Baxter International Inc. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the market.

Additional benefits you will get with this purchase are:
  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
      • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
    • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk t%li%the sales executive t%li%know more)
  • Regulatory Guidelines
    • Additional company profiles with specific t%li%client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario
Key Market Segments

By Service
  • Immune boosters
  • Energy boosters
  • Skin care
  • Migraine
  • Others
By Component
  • Medicated
  • Non-medicated
By End User
  • Hospital clinics
  • Wellness centers spas
  • Home healthcare
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA
  • Key Market Players
  • Davita
    • Nikkis%li%Co. Ltd.
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd.
  • B. Braun Medical Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • NexGen Health
  • JW Life Science Corporation
  • Amanta Healthcare Limited.
  • Baxter International Inc.?
CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: ZERO EMISSION BUILDING MARKET, BY ELEMENT TYPE

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Element Type
4.2. Lighting
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Walls Roofs
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Heating, Ventilation, And Air Conditioning (HVAC) Systems
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country
4.5. Others
  4.5.1. Key Market Trends, Growth Factors and Opportunities
  4.5.2. Market Size and Forecast, By Region
  4.5.3. Market Share Analysis, By Country

CHAPTER 5: ZERO EMISSION BUILDING MARKET, BY BUILDING TYPE

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Building Type
5.2. Residential
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Commercial
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country

CHAPTER 6: ZERO EMISSION BUILDING MARKET, BY REGION

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Region
6.2. North America
  6.2.1. Key Market Trends and Opportunities
  6.2.2. Market Size and Forecast, By Element Type
  6.2.3. Market Size and Forecast, By Building Type
  6.2.4. Market Size and Forecast, By Country
  6.2.5. U.S. Zero Emission Building Market
    6.2.5.1. Market Size and Forecast, By Element Type
    6.2.5.2. Market Size and Forecast, By Building Type
  6.2.6. Canada Zero Emission Building Market
    6.2.6.1. Market Size and Forecast, By Element Type
    6.2.6.2. Market Size and Forecast, By Building Type
  6.2.7. Mexico Zero Emission Building Market
    6.2.7.1. Market Size and Forecast, By Element Type
    6.2.7.2. Market Size and Forecast, By Building Type
6.3. Europe
  6.3.1. Key Market Trends and Opportunities
  6.3.2. Market Size and Forecast, By Element Type
  6.3.3. Market Size and Forecast, By Building Type
  6.3.4. Market Size and Forecast, By Country
  6.3.5. France Zero Emission Building Market
    6.3.5.1. Market Size and Forecast, By Element Type
    6.3.5.2. Market Size and Forecast, By Building Type
  6.3.6. Germany Zero Emission Building Market
    6.3.6.1. Market Size and Forecast, By Element Type
    6.3.6.2. Market Size and Forecast, By Building Type
  6.3.7. Italy Zero Emission Building Market
    6.3.7.1. Market Size and Forecast, By Element Type
    6.3.7.2. Market Size and Forecast, By Building Type
  6.3.8. Spain Zero Emission Building Market
    6.3.8.1. Market Size and Forecast, By Element Type
    6.3.8.2. Market Size and Forecast, By Building Type
  6.3.9. UK Zero Emission Building Market
    6.3.9.1. Market Size and Forecast, By Element Type
    6.3.9.2. Market Size and Forecast, By Building Type
  6.3.10. Russia Zero Emission Building Market
    6.3.10.1. Market Size and Forecast, By Element Type
    6.3.10.2. Market Size and Forecast, By Building Type
  6.3.11. Rest of Europe Zero Emission Building Market
    6.3.11.1. Market Size and Forecast, By Element Type
    6.3.11.2. Market Size and Forecast, By Building Type
6.4. Asia-Pacific
  6.4.1. Key Market Trends and Opportunities
  6.4.2. Market Size and Forecast, By Element Type
  6.4.3. Market Size and Forecast, By Building Type
  6.4.4. Market Size and Forecast, By Country
  6.4.5. China Zero Emission Building Market
    6.4.5.1. Market Size and Forecast, By Element Type
    6.4.5.2. Market Size and Forecast, By Building Type
  6.4.6. Japan Zero Emission Building Market
    6.4.6.1. Market Size and Forecast, By Element Type
    6.4.6.2. Market Size and Forecast, By Building Type
  6.4.7. India Zero Emission Building Market
    6.4.7.1. Market Size and Forecast, By Element Type
    6.4.7.2. Market Size and Forecast, By Building Type
  6.4.8. South Korea Zero Emission Building Market
    6.4.8.1. Market Size and Forecast, By Element Type
    6.4.8.2. Market Size and Forecast, By Building Type
  6.4.9. Australia Zero Emission Building Market
    6.4.9.1. Market Size and Forecast, By Element Type
    6.4.9.2. Market Size and Forecast, By Building Type
  6.4.10. Thailand Zero Emission Building Market
    6.4.10.1. Market Size and Forecast, By Element Type
    6.4.10.2. Market Size and Forecast, By Building Type
  6.4.11. Malaysia Zero Emission Building Market
    6.4.11.1. Market Size and Forecast, By Element Type
    6.4.11.2. Market Size and Forecast, By Building Type
  6.4.12. Indonesia Zero Emission Building Market
    6.4.12.1. Market Size and Forecast, By Element Type
    6.4.12.2. Market Size and Forecast, By Building Type
  6.4.13. Rest of Asia-Pacific Zero Emission Building Market
    6.4.13.1. Market Size and Forecast, By Element Type
    6.4.13.2. Market Size and Forecast, By Building Type
6.5. LAMEA
  6.5.1. Key Market Trends and Opportunities
  6.5.2. Market Size and Forecast, By Element Type
  6.5.3. Market Size and Forecast, By Building Type
  6.5.4. Market Size and Forecast, By Country
  6.5.5. Brazil Zero Emission Building Market
    6.5.5.1. Market Size and Forecast, By Element Type
    6.5.5.2. Market Size and Forecast, By Building Type
  6.5.6. South Africa Zero Emission Building Market
    6.5.6.1. Market Size and Forecast, By Element Type
    6.5.6.2. Market Size and Forecast, By Building Type
  6.5.7. Saudi Arabia Zero Emission Building Market
    6.5.7.1. Market Size and Forecast, By Element Type
    6.5.7.2. Market Size and Forecast, By Building Type
  6.5.8. UAE Zero Emission Building Market
    6.5.8.1. Market Size and Forecast, By Element Type
    6.5.8.2. Market Size and Forecast, By Building Type
  6.5.9. Argentina Zero Emission Building Market
    6.5.9.1. Market Size and Forecast, By Element Type
    6.5.9.2. Market Size and Forecast, By Building Type
  6.5.10. Rest of LAMEA Zero Emission Building Market
    6.5.10.1. Market Size and Forecast, By Element Type
    6.5.10.2. Market Size and Forecast, By Building Type

CHAPTER 7: COMPETITIVE LANDSCAPE

7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023

CHAPTER 8: COMPANY PROFILES

8.1. Skanska AB
  8.1.1. Company Overview
  8.1.2. Key Executives
  8.1.3. Company Snapshot
  8.1.4. Operating Business Segments
  8.1.5. Product Portfolio
  8.1.6. Business Performance
  8.1.7. Key Strategic Moves and Developments
8.2. Bouygues Construction
  8.2.1. Company Overview
  8.2.2. Key Executives
  8.2.3. Company Snapshot
  8.2.4. Operating Business Segments
  8.2.5. Product Portfolio
  8.2.6. Business Performance
  8.2.7. Key Strategic Moves and Developments
8.3. Turner Construction Company
  8.3.1. Company Overview
  8.3.2. Key Executives
  8.3.3. Company Snapshot
  8.3.4. Operating Business Segments
  8.3.5. Product Portfolio
  8.3.6. Business Performance
  8.3.7. Key Strategic Moves and Developments
8.4. Siemens AG
  8.4.1. Company Overview
  8.4.2. Key Executives
  8.4.3. Company Snapshot
  8.4.4. Operating Business Segments
  8.4.5. Product Portfolio
  8.4.6. Business Performance
  8.4.7. Key Strategic Moves and Developments
8.5. Johnson Controls International Plc
  8.5.1. Company Overview
  8.5.2. Key Executives
  8.5.3. Company Snapshot
  8.5.4. Operating Business Segments
  8.5.5. Product Portfolio
  8.5.6. Business Performance
  8.5.7. Key Strategic Moves and Developments
8.6. Schneider Electric
  8.6.1. Company Overview
  8.6.2. Key Executives
  8.6.3. Company Snapshot
  8.6.4. Operating Business Segments
  8.6.5. Product Portfolio
  8.6.6. Business Performance
  8.6.7. Key Strategic Moves and Developments
8.7. Tesla, Inc.
  8.7.1. Company Overview
  8.7.2. Key Executives
  8.7.3. Company Snapshot
  8.7.4. Operating Business Segments
  8.7.5. Product Portfolio
  8.7.6. Business Performance
  8.7.7. Key Strategic Moves and Developments
8.8. SunPower Corporation
  8.8.1. Company Overview
  8.8.2. Key Executives
  8.8.3. Company Snapshot
  8.8.4. Operating Business Segments
  8.8.5. Product Portfolio
  8.8.6. Business Performance
  8.8.7. Key Strategic Moves and Developments
8.9. Mitsubishi Electric Corporation
  8.9.1. Company Overview
  8.9.2. Key Executives
  8.9.3. Company Snapshot
  8.9.4. Operating Business Segments
  8.9.5. Product Portfolio
  8.9.6. Business Performance
  8.9.7. Key Strategic Moves and Developments
8.10. GreenTree Global.
  8.10.1. Company Overview
  8.10.2. Key Executives
  8.10.3. Company Snapshot
  8.10.4. Operating Business Segments
  8.10.5. Product Portfolio
  8.10.6. Business Performance
  8.10.7. Key Strategic Moves and Developments


More Publications